BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2964955)

  • 1. T cell blast stimulation of MLR: role of interleukin 1 and interleukin 2.
    Aaron S
    Clin Exp Immunol; 1988 Jan; 71(1):171-6. PubMed ID: 2964955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Requirement of Ia-positive accessory cells in the MLR response against class II antigen on human B cell tumor line.
    Yamamoto M; Yano A
    J Immunol; 1985 Dec; 135(6):3887-96. PubMed ID: 2999233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human dendritic cells stimulate allogeneic T cells in the absence of IL-1.
    McKenzie JL; Prickett TC; Hart DN
    Immunology; 1989 Jul; 67(3):290-7. PubMed ID: 2527194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Possible involvement of the CD4 molecule in a late activation event on CD4+ T cell proliferation in the human autologous mixed lymphocyte reaction.
    Sakane T; Takada S
    Clin Exp Immunol; 1989 Feb; 75(2):269-74. PubMed ID: 2522840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of CD80 expression by fibroblast-like synoviocytes leading to anergy in T lymphocytes.
    Corrigall VM; Solau-Gervais E; Panayi GS
    Arthritis Rheum; 2000 Jul; 43(7):1606-15. PubMed ID: 10902766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human alveolar macrophages: HLA-DR-positive macrophages that are poor stimulators of a primary mixed leukocyte reaction.
    Lipscomb MF; Lyons CR; Nunez G; Ball EJ; Stastny P; Vial W; Lem V; Weissler J; Miller LM
    J Immunol; 1986 Jan; 136(2):497-504. PubMed ID: 2934472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T cell-dependent activation of B cell proliferation and differentiation by immobilized monoclonal antibodies to CD3.
    Hirohata S; Jelinek DF; Lipsky PE
    J Immunol; 1988 Jun; 140(11):3736-44. PubMed ID: 2967324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of B cells in the stimulation of syngeneic mixed lymphocyte responses.
    Thorbecke GJ; Chapman-Alexander J; Katz IR; Bienenstock A; Asofsky R
    Behring Inst Mitt; 1983 May; (72):107-16. PubMed ID: 6242330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mouse T lymphocytes proliferative responses specific for human MHC products in mouse anti-human xenogeneic MLR.
    Yoshizawa K; Yano A
    J Immunol; 1984 Jun; 132(6):2820-9. PubMed ID: 6202762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-4/B cell stimulatory factor 1 stimulates T cell growth by an IL-2-independent mechanism.
    Brown M; Hu-Li J; Paul WE
    J Immunol; 1988 Jul; 141(2):504-11. PubMed ID: 3133410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Valency of CD3 binding and internalization of the CD3 cell-surface complex control T cell responses to second signals: distinction between effects on protein kinase C, cytoplasmic free calcium, and proliferation.
    Ledbetter JA; June CH; Martin PJ; Spooner CE; Hansen JA; Meier KE
    J Immunol; 1986 Jun; 136(11):3945-52. PubMed ID: 3084650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Requirements for T cell activation by OKT3 monoclonal antibody: role of modulation of T3 molecules and interleukin 1.
    Schwab R; Crow MK; Russo C; Weksler ME
    J Immunol; 1985 Sep; 135(3):1714-8. PubMed ID: 3926880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concanavalin A triggers T lymphocytes by directly interacting with their receptors for activation.
    Palacios R
    J Immunol; 1982 Jan; 128(1):337-42. PubMed ID: 6459373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a membrane antigen that is distinct from the interleukin 2 receptor and that may be required for interleukin 2-driven proliferative responses.
    Malek TR; Robb RJ; Shevach EM
    J Immunol; 1983 Feb; 130(2):747-55. PubMed ID: 6184403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of interleukin 2 receptiveness and proliferation in resting peripheral T cells by monoclonal anti-CD3 (T3) antibodies does not require the presence of macrophages.
    Stingl LA; Sinska A; Landesmann U; Smolen JS
    Clin Exp Immunol; 1987 Apr; 68(1):146-55. PubMed ID: 3115639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody binding to CD5 (Tp67) and Tp44 T cell surface molecules: effects on cyclic nucleotides, cytoplasmic free calcium, and cAMP-mediated suppression.
    Ledbetter JA; Parsons M; Martin PJ; Hansen JA; Rabinovitch PS; June CH
    J Immunol; 1986 Nov; 137(10):3299-305. PubMed ID: 3021852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of resting T lymphocytes by anti-CD3 (T3) antibodies in the absence of monocytes.
    Tsoukas CD; Landgraf B; Bentin J; Valentine M; Lotz M; Vaughan JH; Carson DA
    J Immunol; 1985 Sep; 135(3):1719-23. PubMed ID: 3926881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hodgkin's disease cell lines: a model for interleukin-1-independent accessory cell function.
    McKenzie JL; Egner W; Calder VL; Hart DN
    Immunology; 1992 Nov; 77(3):345-53. PubMed ID: 1478681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of interleukin-2 (IL-2) in the differentiatin of cytotoxic T cells: the effect of monoclonal anti-IL-2 antibody and absorption with IL-2 dependent T cell lines.
    Kern DE; Gillis S; Okada M; Henney CS
    J Immunol; 1981 Oct; 127(4):1323-8. PubMed ID: 6456304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoclonal antibodies to the CD5 antigen can provide the necessary second signal for activation of isolated resting T cells by solid-phase-bound OKT3.
    Ceuppens JL; Baroja ML
    J Immunol; 1986 Sep; 137(6):1816-21. PubMed ID: 3091691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.